EP0269127A3 - Nucleotide sequences which are selectively expressed in pre-b cells and probes therefor - Google Patents

Nucleotide sequences which are selectively expressed in pre-b cells and probes therefor Download PDF

Info

Publication number
EP0269127A3
EP0269127A3 EP19870117619 EP87117619A EP0269127A3 EP 0269127 A3 EP0269127 A3 EP 0269127A3 EP 19870117619 EP19870117619 EP 19870117619 EP 87117619 A EP87117619 A EP 87117619A EP 0269127 A3 EP0269127 A3 EP 0269127A3
Authority
EP
European Patent Office
Prior art keywords
cells
selectively expressed
nucleotide sequences
probe
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP19870117619
Other languages
German (de)
French (fr)
Other versions
EP0269127B1 (en
EP0269127A2 (en
Inventor
Steven R. Dr. Bauer
Akira Dr. Kudo
Georg Friedrich Prof. Dr. Melchers
Nobuo Dr. C/O Dept. Of Immunology Sakaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628433A external-priority patent/GB8628433D0/en
Priority claimed from GB878724100A external-priority patent/GB8724100D0/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of EP0269127A2 publication Critical patent/EP0269127A2/en
Publication of EP0269127A3 publication Critical patent/EP0269127A3/en
Application granted granted Critical
Publication of EP0269127B1 publication Critical patent/EP0269127B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to nucleotide sequences which are selectively expressed in pre-B cells, to a probe comprising a polynucleotide hybridizing specifically to such a nucleotide sequence and to a method for the production of such a probe. Said probe may be used for determining pre-B cells. The invention further relates to polypeptides translated from a transcript comprising a nucleotide sequence which is selectively expressed in pre-B cells or parts thereof, to antibodies against said polypeptides and to methods for the preparation and the use of said polypeptides and the antibodies raised against them.
EP19870117619 1986-11-27 1987-11-27 Nucleotide sequences which are selectively expressed in pre-B cells and probes therefor Expired - Lifetime EP0269127B1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8628433 1986-11-27
GB868628433A GB8628433D0 (en) 1986-11-27 1986-11-27 Nucleotide sequence
GB8716497 1987-07-14
GB878716497A GB8716497D0 (en) 1986-11-27 1987-07-14 Nucleotide sequences
GB8724100 1987-10-14
GB878724100A GB8724100D0 (en) 1986-11-27 1987-10-14 Nucleotide sequences

Publications (3)

Publication Number Publication Date
EP0269127A2 EP0269127A2 (en) 1988-06-01
EP0269127A3 true EP0269127A3 (en) 1991-03-13
EP0269127B1 EP0269127B1 (en) 1994-02-23

Family

ID=27263220

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870117619 Expired - Lifetime EP0269127B1 (en) 1986-11-27 1987-11-27 Nucleotide sequences which are selectively expressed in pre-B cells and probes therefor

Country Status (2)

Country Link
EP (1) EP0269127B1 (en)
DE (1) DE3789138T2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69719726T2 (en) * 1997-03-27 2003-10-16 Council Of Scientific And Industrial Research, New Delhi Procedure for the detection of leukemia
EP1001020A4 (en) * 1997-07-29 2005-03-02 Sumitomo Electric Industries Antihuman pre-b cell receptor antibodies
EP2132312B1 (en) 2007-03-27 2016-01-27 Sea Lane Biotechnologies,llc. Constructs and libraries comprising antibody surrogate light chain sequences
AU2010249046A1 (en) 2009-05-13 2011-12-01 Sea Lane Biotechnologies, Llc Neutralizing molecules to influenza viruses
EP2446032B8 (en) 2009-06-26 2017-03-15 i2 Pharmaceuticals, Inc. Expression of surrogate light chains
US10300140B2 (en) 2011-07-28 2019-05-28 I2 Pharmaceuticals, Inc. Sur-binding proteins against ERBB3
EP3446707A1 (en) 2011-12-22 2019-02-27 i2 Pharmaceuticals, Inc. Surrogate binding proteins
EP4177267A1 (en) 2015-02-02 2023-05-10 Children's Health Care d/b/a Children's Minnesota Anti-surrogate light chain antibodies

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
NATURE, vol. 311, 25th October 1984, pages 727-733; G.D. YANCOPOULOS et al.: "Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines" *
THE EMBO JOURNAL, vol. 5, no. 9, September 1986, pages 2139-2147, IRL Press Ltd, Oxford, GB; N. SAKAGUCHI et al.: "Isolation of a cDNA copy of an RNA species expressed in murine pre-B cells" *
THE EMBO JOURNAL, vol. 6, no. 1, January 1987, pages 103-107, IRL Press Ltd, Oxford, GB; A. KUDO et al.: "Organization of the murine Ig-related lambda5 gene transcribed selectively in pre-B lymphocytes" *
THE EMBO JOURNAL, vol. 6, no. 8, August 1987, pages 2267-2272, IRL Press Ltd, Oxford, GB; A. KUDO et al.: "A second gene, VpreB in the lambda5 locus of the mouse, which appears to be selectively expressed in pre-B lymphocytes" *

Also Published As

Publication number Publication date
DE3789138D1 (en) 1994-03-31
EP0269127B1 (en) 1994-02-23
EP0269127A2 (en) 1988-06-01
DE3789138T2 (en) 1994-05-26

Similar Documents

Publication Publication Date Title
ES8609472A1 (en) Use of non-hybridizable nucleic acids for the detection of nucleic acid hybridization
CA2020958A1 (en) Nucleic acid sequence amplification methods
DE3481775D1 (en) METHOD FOR RAPID DETECTION OF MICROORGANISMS IN CLINICAL SAMPLES.
EP1630235A3 (en) Compounds for immunodiagnosis of prostate cancer and method for their use
EP0361983A3 (en) Rna template end-linked probe constructs and methods for use
HK1026003A1 (en) Method of preparing a standard diagnostic gene transcript pattern.
ES8506168A1 (en) Methods and structures employing non-radioactive chemically-labeled polynucleotide probes.
ATE58537T1 (en) PROCESS FOR THE PREPARATION OF IMIDAZOPYRIDINES.
GB8729731D0 (en) Hybridization method & probe for detecting nucleic acid sequences
NZ331866A (en) Compounds for immunotherapy and immunodiagnosis of prostate cancer
CA2076979A1 (en) Substantially pure transforming growth factor-.beta.-1-binding protein and nucleotide sequences expressing the binding protein
DE3788742D1 (en) Process for the production of block copolymers.
DE3751366D1 (en) Signal processing method for determining the basic structure of nucleic acids.
ATA208987A (en) IMMORTALIZED CELL LINE, METHOD FOR THEIR PRODUCTION AND METHOD FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES, AND DIAGNOSTIC METHODS AND MEANS
DE3787515D1 (en) Procedure for the online calculation and control of alcoholic fermentations.
DE3767835D1 (en) METHOD FOR THE PRODUCTION OF FLUORO-HALOGEN ETHERS, STARTING FROM FLUOROXY COMPOUNDS AND HALOGENED OLEFINS.
EP0269127A3 (en) Nucleotide sequences which are selectively expressed in pre-b cells and probes therefor
DE3787998D1 (en) ART nucleotide segments, vectors, cell lines, methods of production and use.
DE3788828D1 (en) Stabilized liquid enzyme composition for the determination of glucose.
EP0128018A3 (en) Molecular genetic probe, and method of forming same, assay technique and kit using said molecular genetic probe
DE3887197D1 (en) Process for the preparation of glucose dehydrogenase from Bacillus megaterium.
DE3683165D1 (en) ANALYTICAL ELEMENT, COMPOSITION, KIT AND METHOD FOR DETERMINING THEOPHYLLINE BY ENZYME INHIBITION.
DE3789833D1 (en) Isolated phenylalanine dehydrogenase gene and method for producing phenylalanine dehydrogenase.
DE3750779D1 (en) Enzyme sensor and method of making the same.
DE69021239D1 (en) Process for the preparation of ellagic acid.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19871127

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): CH DE FR GB IT LI NL

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: F. HOFFMANN-LA ROCHE AG

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): CH DE FR GB IT LI NL

17Q First examination report despatched

Effective date: 19920123

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): CH DE FR GB IT LI NL

REF Corresponds to:

Ref document number: 3789138

Country of ref document: DE

Date of ref document: 19940331

ITF It: translation for a ep patent filed
ET Fr: translation filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19941013

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19941102

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19941115

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19941118

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19941130

Year of fee payment: 8

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19951127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19951130

Ref country code: CH

Effective date: 19951130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19960601

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19951127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Effective date: 19960731

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 19960601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19960801

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20051127